查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2040360

家用採血試劑盒及設備市場規模、佔有率及趨勢分析報告：依產品類型、應用、設備類型、地區及細分市場預測（2026-2033 年）

At-home Blood Collection Kits And Devices Market Size, Share & Trends Analysis Report By Product, By Application, By Device Type, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

家用採血試劑盒和設備市場概述

2025年全球家用採血試劑盒和設備的市場規模估計為1.9342億美元，預計2033年將達到3.8197億美元。

預計從2026年到2033年，該產業將以8.92%的複合年成長率成長。血液相關疾病負擔的加重是這一成長的主要促進因素。

人們對以患者為中心的預防醫學的日益關注、遠端醫療和遠端患者監護的快速普及以及分散式臨床試驗（DCT）的擴展，都在進一步推動市場成長。例如，2025年8月發表在《微化學雜誌》（Microchemical Journal）上的一項研究強調，居家毛細血管採血將使診斷更加便捷和可重複，尤其是在服務不足的人群中，從而擴大醫療保健覆蓋範圍。

貧血、缺鐵、糖尿病和高血脂症等血液疾病的日益普遍，是推動全球家用採血試劑盒和設備產業發展的主要動力。對於這些疾病而言，早期發現、頻繁的診斷檢測、持續監測和長期追蹤至關重要。例如，根據世界衛生組織2025年的報告，貧血將影響全球約24.3%的人口，約16億人。 2023年，全球15至49歲女性的盛行率為30.7%，6至59個月齡嬰兒的盛行率為39.8%。家用採血解決方案能夠便捷地進行重複性檢體採集，減少患者就醫次數，提高患者依從性，並支持數據驅動的及時疾病管理，從而有效滿足這些需求。此外，許多血液疾病是慢性且終身的，需要定期進行血紅蛋白檢測、血小板監測和血液凝固檢驗，因此對便捷診斷解決方案的需求持續存在。最近的研究表明，家庭毛細血管採血正在大力推動家庭採血設備的普及，尤其是在服務不足的地區，因為它可以改善醫療服務獲取途徑，支持定期診斷，提高患者依從性，並擴大醫療保健服務的範圍。

全球醫療保健正朝著預防性和以患者為中心的方向發展，這推動了家用採血試劑盒和設備市場的成長。隨著患者越來越積極主動監測自身健康狀況並及早發現疾病，以往在臨床檢查室進行的常規血液檢測擴大在家中進行。這種對預防、自我管理和便利性的重視顯著提高了家用採血設備的普及率，使人們無需前往醫院即可進行定期健康檢查、早期發現疾病和持續監測。對即時、分散式診斷的需求日益成長，尤其是在糖尿病、貧血和感染疾病等慢性疾病方面，進一步增強了對家用檢測解決方案的支持。家用採血設備具有便利性、可近性和增強患者自主性的優勢，可與數位健康平台和遠端醫療服務相結合，支援預防性護理和持續監測。例如，2024年4月，Drawbridge Health公司的NanoDrop家用採血設備獲得FDA 510(k)商業化批准，標誌著消費者採血技術取得了重大進展。 NanoDrop 創新的雙採血針設計，只需按一下按鈕，即可讓人們在家中輕鬆無痛地採集全血樣本，顯著提高了日常健康監測、慢性病管理和分散式臨床研究的便利性和可及性。

遠距遠端醫療服務和遠端患者監護(RPM) 的快速發展是市場成長的主要驅動力。隨著醫療服務提供者不斷增加虛擬醫療服務，對準確可靠的居家血液檢體的需求激增，這使得臨床醫生無需患者到場即可及時做出決策。居家採血套裝和設備支援這項轉變，使患者能夠在家中輕鬆採集檢體，安全地將其發送至實驗室，並結合遠距遠端醫療平台接收即時臨床評估。這些套裝通常包含專用卡的指尖採血針或先進易用的上臂採血設備，便於進行遠端慢性病監測、預防醫學和常規健康檢查，從而減少患者就醫次數和長時間等待。這些設備提供便利、安全且方便用戶使用的解決方案，包括 Tasso、RedDrop 和 Capitainer SEP10 卡等技術，以及可選的專業採血服務，從而提高患者參與度和臨床效率。例如，美國遠端醫療協會特別興趣小組（SIG）成立於2021年9月，旨在促進家庭診斷檢測與遠距醫療相結合的廣泛應用。透過倡導促進家庭檢體採集和支持遠端醫療的政策，這些努力凸顯了遠端醫療的擴展如何為家庭採血設備創造有利環境，並反映了更廣泛的市場趨勢，即向去中心化、以患者為中心的醫療保健模式發展。

分散式臨床試驗 (DCT) 的擴展是家用採血試劑盒和設備市場的重要成長要素。這是因為許多試驗活動正從傳統的科學研究機構轉移到參與者的家中和當地環境。 DCT 透過遠端監測、遠距遠端醫療諮詢、電子知情同意 (eConsent) 和居家檢體採集等程序，減輕了患者的負擔並提高了試驗的可及性。這使得更廣泛的參與者能夠參與試驗，並確保受試者群體更具代表性。這些試驗有助於申辦方最佳化營運成本，提高受試者招募和保留率，並透過最大限度地減少頻繁的醫院就診來加快試驗進度。近期市場數據顯示，DCT 的數量激增，分散式和混合式試驗設計擴大應用於糖尿病、腫瘤和罕見疾病等治療領域。例如，一篇發表於 2026 年 PLOS Digital Health 的論文分析了 ClinicalTrials.gov 網站，報告指出分散式臨床試驗的數量穩步成長。作為試驗方案的一部分，試驗物流（包括居家檢體採集和生物檢體運輸）也在顯著擴展。這些趨勢正在推動對可靠的家用採血試劑盒和設備的需求，這些試劑盒和設備能夠在臨床環境之外檢體，以支持分散式試驗的終點指標。隨著製藥公司和合約研究組織 (CRO) 更廣泛地採用分散式臨床試驗 (DCT)，家用採血技術正成為遠端臨床研究的關鍵基礎設施，加速市場接受度並推動成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 家用採血試劑盒和設備的市場：變數、趨勢和範圍

  • 市場譜系展望
  • 市場動態
  • 家用採血試劑盒和設備市場分析工具

第4章：家用採血試劑盒及設備市場：產品具體估算及趨勢分析

  • 按產品分類的市場佔有率，2025 年和 2033 年
  • 全球家用採血試劑盒及設備市場：依產品分類，展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 乾血斑 (DBS) 試劑盒
  • 微量取樣裝置
  • 指尖採血工具包
  • 《採血針》
  • 微血管採血管
  • 其他

第5章：家用採血試劑盒和設備市場：按應用分類的估算和趨勢分析

  • 按應用領域分類的市場佔有率，2025 年和 2033 年
  • 全球家用採血試劑盒及設備市場：依應用領域分類，展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 慢性病監測
  • 傳染病檢查
  • 基因和荷爾蒙檢測
  • 預防醫學/健康

第6章：家用採血試劑盒和設備市場：按設備類型分類的估算和趨勢分析

  • 按設備類型分類的市場佔有率，2025 年和 2033 年
  • 全球家用採血試劑盒及設備市場：依設備類型分類，展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 自採血裝置
  • 家用設備，並提供專家支持

第7章：家用採血試劑盒及設備市場：區域估算及趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 全球市場概述（按地區分類）
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 主要市場參與企業近期趨勢及影響分析
  • 公司和競爭對手的分類
  • 供應商情況
    • 主要銷售代理商和通路夥伴名單
    • Key customers
    • Key company market share analysis, 2025
    • BD
    • Tasso. Inc.
    • Trajan Group Holdings Limited
    • Capitainer AB
    • A. Menarini Diagnostics
    • R-Biopharm AG
    • Owen Mumford Ltd
    • Spot On Sciences
    • RedDrop Dx, Inc.
    • Drawbridge Health, Inc.
Product Code: GVR-4-68040-889-0

At-home Blood Collection Kits And Devices Market Summary

The global at-home blood collection kits and devices market size was estimated at USD 193.42 million in 2025 and is anticipated to reach USD 381.97 million by 2033, growing at a CAGR of 8.92% from 2026 to 2033. The rising burden of blood-related disorders primarily drives the growth.

The growing emphasis on patient-centric and preventive healthcare, the rapid adoption of telehealth and remote patient monitoring, and the expansion of decentralized clinical trials (DCTs) further support the market expansion. For instance, a study published in the Microchemical Journal in August 2025 highlights that home-based capillary blood testing enables accessible, repeat diagnostics and expands healthcare coverage, especially in underserved populations.

The increasing prevalence of blood-related disorders, such as anemia, Iron Deficiency, Diabetes Mellitus, and Hyperlipidemia, is a primary driver of the global at-home blood collection kits and devices industry. These conditions necessitate frequent diagnostic testing, ongoing monitoring, and early detection with continuous follow-up. For instance, according to the WHO 2025 report, anemia affects approximately 24.3% of the world's population, or around 1.6 billion people. In 2023, 30.7% of women aged 15-49 and 39.8% of children aged 6-59 months globally were affected by the condition. At-home blood collection solutions effectively address these needs by enabling convenient and repeat sample collection, reducing dependence on hospital visits, improving patient compliance, and supporting timely, data-driven disease management. Furthermore, many blood disorders are chronic and lifelong, necessitating routine hemoglobin checks, platelet monitoring, and coagulation testing, which drives recurring demand for convenient diagnostic solutions. Recent research shows that at-home capillary blood testing improves accessibility, supports repeat diagnostics, enhances patient compliance, and expands healthcare coverage, particularly in underserved populations, strongly promoting the adoption of at-home blood collection devices.

There is a strong global shift toward preventive, patient-centric healthcare, which is driving growth in the at-home blood collection kits and devices market. As patients become more proactive in monitoring their health and detecting conditions early, routine blood testing traditionally performed in clinical laboratories is increasingly being conducted at home. This emphasis on prevention, self-management, and convenience has significantly increased adoption of at-home blood collection devices, enabling regular health checks, early disease detection, and ongoing monitoring without hospital visits. The rising demand for real-time, decentralized diagnostics, particularly for chronic conditions such as diabetes, anemia, and infectious diseases, has reinforced the preference for home-based testing solutions. At-home blood collection devices provide convenience, accessibility, and patient empowerment, supporting preventive care and continuous monitoring while integrating with digital health platforms and remote physician services. For instance, in April 2024, Drawbridge Health's NanoDrop at-home blood sampling device received FDA 510(k) clearance for over-the-counter use, marking a significant advancement in consumer blood collection technology. NanoDrop's novel dual nano-lancet design allows individuals to obtain whole-blood samples easily and painlessly at home with the press of a button, greatly enhancing convenience and accessibility for routine health monitoring, chronic disease management, and decentralized clinical research.

The rapid expansion of telehealth services and remote patient monitoring (RPM) is significantly driving the market growth. As healthcare providers increasingly deliver care virtually, the demand for accurate, reliable home-collected blood samples has surged, enabling clinicians to make timely decisions without requiring in-person visits. At-home blood collection kits and devices support this shift by allowing patients to conveniently collect samples at home, which can then be securely transmitted to laboratories or integrated with telehealth platforms for real-time clinical review. These kits often include lancets for finger-prick sampling on specialized cards or advanced, user-friendly on-arm devices, facilitating remote chronic disease monitoring, preventive care, and routine health checks, reducing the need for travel and long wait times. By providing accessible, safe, and easy-to-use solutions, including technologies such as Tasso, RedDrop, and Capitainer SEP10 cards, as well as optional professional phlebotomy services, these devices enhance patient engagement and clinical efficiency. For instance, the American Telemedicine Association's Home Testing Special Interest Group (SIG), launched in September 2021, aims to accelerate the adoption of home diagnostic testing integrated with virtual care. By promoting home sample collection and advocating supportive telehealth policies, these initiatives underscore how telehealth expansion creates a strong enabling environment for at-home blood collection devices, reflecting broader market momentum toward decentralized, patient-centric healthcare.

The expansion of decentralized clinical trials (DCTs) is a significant growth driver for the at-home blood collection kits and devices market, as it shifts many trial activities from traditional research sites to participants' homes or local settings. In DCTs, procedures such as remote monitoring, telemedicine visits, eConsent, and at-home sample collection reduce patient burden and increase accessibility, enabling broader participation and more representative study populations. These trials help sponsors optimize operational costs, improve recruitment and retention, and accelerate timelines by minimizing the need for frequent clinic visits. Recent market data indicate a sharp increase in DCTs, with decentralized and hybrid designs increasingly employed across therapeutic areas such as diabetes, oncology, and rare diseases. For instance, a 2026 analysis in PLOS Digital Health, reviewing ClinicalTrials.gov, documented the steady rise in decentralized clinical trials. Home sample collection and trial logistics, including the shipping of biological specimens, have grown significantly as part of trial protocols. These developments reinforce the demand for reliable at-home blood collection kits and devices capable of capturing high-quality samples outside clinical environments to support decentralized study endpoints. As pharmaceutical companies and contract research organizations adopt DCTs more broadly, at-home blood collection technologies are becoming essential infrastructure for remote clinical research, thereby accelerating market acceptance and driving growth.

Global At-home Blood Collection Kits And Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of industry trends in each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global at-home blood collection kits and devices market report based on product, device type, application, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Dried Blood Spot (DBS) Kits
  • Micro-sampling Devices
  • Fingerstick Blood Collection Kits
  • Lancets
  • Capillary Blood Collection Tubes
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Chronic disease monitoring
  • Infectious disease testing
  • Genetic & hormonal testing
  • Preventive health/wellness
  • Device Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Self-Collection Devices
  • Professional-assisted home devices
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Device type
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. Device type Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. At-home Blood Collection Kits and Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of blood-related disorders
      • 3.2.1.2. The growing emphasis on patient-centric and preventive healthcare,
      • 3.2.1.3. Rapid adoption of telehealth and remote patient monitoring,
      • 3.2.1.4. Expansion of decentralized clinical trials (DCTs)
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Regulatory and compliance challenges
      • 3.2.2.2. Sample collection errors and user compliance
  • 3.3. At-home Blood Collection Kits and Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. At-home Blood Collection Kits and Devices Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global At-home Blood Collection Kits and Devices Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Dried Blood Spot (DBS) Kits
    • 4.5.1. Dried Blood Spot (DBS) Kits Market, 2021 - 2033 (USD Million)
  • 4.6. Micro-sampling Devices
    • 4.6.1. Micro-sampling Devices Market, 2021 - 2033 (USD Million)
  • 4.7. Fingerstick Blood Collection Kits
    • 4.7.1. Fingerstick Blood Collection Kits Market, 2021 - 2033 (USD Million)
  • 4.8. Lancets
    • 4.8.1. Lancets Market, 2021 - 2033 (USD Million)
  • 4.9. Capillary Blood Collection Tubes
    • 4.9.1. Capillary Blood Collection Tubes Market, 2021 - 2033 (USD Million)
  • 4.10. Others
    • 4.10.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. At-home Blood Collection Kits and Devices Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global At-home Blood Collection Kits and Devices Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Chronic Disease Monitoring
    • 5.5.1. Platelets Aggregation Inhibitors Market, 2021 - 2033 (USD Million)
  • 5.6. Infectious Disease Testing
    • 5.6.1. Infectious Disease Testing Market, 2021 - 2033 (USD Million)
  • 5.7. Genetic & Hormonal Testing
    • 5.7.1. Genetic & Hormonal Testing Market, 2021 - 2033 (USD Million)
  • 5.8. Preventive Health / Wellness
    • 5.8.1. Preventive Health / Wellness Market, 2021 - 2033 (USD Million)

Chapter 6. At-home Blood Collection Kits and Devices Market: Device Type Estimates & Trend Analysis

  • 6.1. Device Type Market Share, 2025 & 2033
  • 6.2. Segment Dashboard
  • 6.3. Global At-home Blood Collection Kits and Devices Market by Device Type Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Self-Collection Devices
    • 6.5.1. Self-Collection Devices Market, 2021 - 2033 (USD Million)
  • 6.6. Professional-Assisted Home Devices
    • 6.6.1. Professional-Assisted Home Devices Market, 2021 - 2033 (USD Million)

Chapter 7. At-home Blood Collection Kits and Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2025
    • 8.3.4. BD
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Tasso. Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Trajan Group Holdings Limited
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Capitainer AB
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. A. Menarini Diagnostics
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. R-Biopharm AG
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Owen Mumford Ltd
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Spot On Sciences
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. RedDrop Dx, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Drawbridge Health, Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 4 Global at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 5 Global at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 6 North America at-home blood collection kits and devices market, by Country, 2021 - 2033 (USD Million)
  • Table 7 North America at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 8 North America at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 9 North America at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 10 U.S. at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 11 U.S. at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 12 U.S. at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 13 Canada at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 14 Canada at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 15 Canada at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 16 Mexico at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 17 Mexico at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 18 Mexico at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 19 Europe at-home blood collection kits and devices market, by Country, 2021 - 2033 (USD Million)
  • Table 20 Europe at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 21 Europe at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 22 Europe at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 23 Germany at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 24 Germany at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 25 Germany at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 26 UK at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 27 UK at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 28 UK at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 29 France at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 30 France at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 31 France at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 32 Italy at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 33 Italy at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 34 Italy at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 35 Spain at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 36 Spain at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 37 Spain at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 38 Denmark at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 39 Denmark at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 40 Denmark at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 41 Sweden at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 42 Sweden at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 43 Sweden at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 44 Norway at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 45 Norway at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 46 Norway at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific at-home blood collection kits and devices market, by Country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 51 China at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 52 China at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 53 China at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 54 Japan at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 55 Japan at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 56 Japan at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 57 India at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 58 India at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 59 India at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 60 South Korea at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 61 South Korea at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 62 South Korea at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 63 Australia at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 64 Australia at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 65 Australia at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 66 Thailand at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 67 Thailand at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 68 Thailand at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 69 Latin America at-home blood collection kits and devices market, by Country, 2021 - 2033 (USD Million)
  • Table 70 Latin America at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 71 Latin America at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 72 Latin America at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 73 Brazil at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 74 Brazil at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 75 Brazil at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 76 Argentina at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 77 Argentina at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 78 Argentina at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 79 Middle East & Africa at-home blood collection kits and devices market, by Country, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 83 South Africa at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 84 South Africa at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 85 South Africa at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 89 UAE at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 90 UAE at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 91 UAE at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)
  • Table 92 Kuwait at-home blood collection kits and devices market, by Product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait at-home blood collection kits and devices market, by Application, 2021 - 2033 (USD Million)
  • Table 94 Kuwait at-home blood collection kits and devices market, by Device Type, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 At-home Blood Collection Kits and devices Market Segmentation
  • Fig. 8 Market Snapshot, 2025
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global at-home blood collection kits and devices market, Sample Movement Analysis
  • Fig. 16 Global At-home Blood Collection Kits and Devices Market: Product Movement Analysis
  • Fig. 17 Global At-home Blood Collection Kits and devices Market, for Dried Blood Spot (DBS) Kits, 2021 - 2033 (USD Million)
  • Fig. 18 Global At-home Blood Collection Kits and devices Market, for Micro-sampling Devices, 2021 - 2033 (USD Million)
  • Fig. 19 Global At-home Blood Collection Kits and devices Market, for Fingerstick Blood Collection Kits, 2021 - 2033 (USD Million)
  • Fig. 20 Global At-home Blood Collection Kits and devices Market, for Lancets, 2021 - 2033 (USD Million)
  • Fig. 21 Global At-home Blood Collection Kits and devices Market, for Capillary Blood Collection Tubes, 2021 - 2033 (USD Million)
  • Fig. 22 Global At-home Blood Collection Kits and devices Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 23 Global At-home Blood Collection Kits and devices Market: Application Type Movement Analysis
  • Fig. 24 Global At-home Blood Collection Kits and devices Market, for Chronic Disease Monitoring, 2021 - 2033 (USD Million)
  • Fig. 25 Global At-home Blood Collection Kits and devices Market, for Infectious Disease Testing, 2021 - 2033 (USD Million)
  • Fig. 26 Global At-home Blood Collection Kits and devices Market, for Genetic & Hormonal Testing, 2021 - 2033 (USD Million)
  • Fig. 27 Global At-home Blood Collection Kits and devices Market, For Preventive Health / Wellness, 2021 - 2033 (USD Million)
  • Fig. 28 Global At-home Blood Collection Kits and devices Market, Device Type Movement Analysis
  • Fig. 29 Global At-home Blood Collection Kits and devices Market, for Self-Collection Devices, 2021 - 2033 (USD Million)
  • Fig. 30 Global At-home Blood Collection Kits and devices Market, for Professional-Assisted Home Devices, 2021 - 2033 (USD Million)
  • Fig. 31 Regional Marketplace: Key Takeaways
  • Fig. 32 Regional Outlook, 2025 & 2033
  • Fig. 33 Global At-home Blood Collection Kits and devices Market, Region Movement Analysis
  • Fig. 34 North America at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 36 Canada at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 37 Mexico at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 38 Europe at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 39 Germany at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 40 UK at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 41 France at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 42 Italy at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 43 Spain at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 44 Denmark at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 45 Sweden at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 46 Norway at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 47 Asia Pacific at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 48 Japan at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 49 China at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 50 India at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 51 Australia at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 52 South Korea at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 53 Thailand at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 54 Latin America at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 55 Brazil at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 56 Argentina at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 57 Middle East and Africa at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 58 South Africa at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 59 Saudi Arabia at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 60 UAE at-home blood collection kits and devices market, 2021 - 2033 (USD Million)
  • Fig. 61 Kuwait at-home blood collection kits and devices market, 2021 - 2033 (USD Million)